Efficacy of vibegron, a novel β3-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc
 analysis of a randomized, placebo-controlled, double-blind, comparative phase 3 study

Editorial Comment to Efficacy of mirabegron, a β 3 ‐adrenoreceptor agonist, in Japanese women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence: Post‐hoc analysis of pooled data from two randomized, placebo‐controlled, double‐blind studies

10.1111/iju.14716 ◽

2021 ◽

Author(s):

Tomonori Yamanishi

Keyword(s):

Urinary Incontinence ◽

Overactive Bladder ◽

Editorial Comment ◽

Japanese Women ◽

Urgency Urinary Incontinence ◽

Mixed Urinary Incontinence ◽

Double Blind ◽

Post Hoc Analysis ◽

Pooled Data ◽

Efficacy of mirabegron, a β 3 ‐adrenoreceptor agonist, in Japanese women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence: Post‐hoc analysis of pooled data from two randomized, placebo‐controlled, double‐blind studies

10.1111/iju.14700 ◽

2021 ◽

Author(s):

Satoru Takahashi ◽

Yuji Mishima ◽

Kentaro Kuroishi ◽

Masashi Ukai

Keyword(s):

Urinary Incontinence ◽

Overactive Bladder ◽

Japanese Women ◽

Urgency Urinary Incontinence ◽

Mixed Urinary Incontinence ◽

Double Blind ◽

Post Hoc Analysis ◽

Pooled Data ◽

Efficacy of novel β 3 ‐adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post‐hoc analysis of a randomized, double‐blind, placebo‐controlled phase 3 study

10.1111/iju.13877 ◽

2018 ◽

Vol 26 (3) ◽

pp. 369-375 ◽

Cited By ~ 9

Author(s):

Masaki Yoshida ◽

Masayuki Takeda ◽

Momokazu Gotoh ◽

Osamu Yokoyama ◽

Hidehiro Kakizaki ◽

...

Keyword(s):

Overactive Bladder ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Editorial Comment to Efficacy of novel β 3 ‐adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post‐hoc analysis of a randomized, double‐blind, placebo‐controlled phase 3 study

10.1111/iju.13892 ◽

2018 ◽

Vol 26 (3) ◽

pp. 375-376

Author(s):

Takeya Kitta

Keyword(s):

Overactive Bladder ◽

Editorial Comment ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Cardiovascular safety of vibegron, a new β3‐adrenoceptor agonist, in older patients with overactive bladder: Post‐hoc analysis of a randomized, placebo‐controlled, double‐blind comparative phase 3 study

Neurourology and Urodynamics ◽

10.1002/nau.24732 ◽

2021 ◽

Author(s):

Masaki Yoshida ◽

Masayuki Takeda ◽

Momokazu Gotoh ◽

Osamu Yokoyama ◽

Hidehiro Kakizaki ◽

...

Keyword(s):

Overactive Bladder ◽

Older Patients ◽

Cardiovascular Safety ◽

Phase 3 ◽

Double Blind ◽

Post Hoc Analysis ◽

Adrenoceptor Agonist ◽

100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies

Headache The Journal of Head and Face Pain ◽

10.1111/head.13427 ◽

2018 ◽

Vol 58 (9) ◽

pp. 1347-1357 ◽

Cited By ~ 16

Author(s):

Noah Rosen ◽

Eric Pearlman ◽

Dustin Ruff ◽

Kathleen Day ◽

Abraham Jim Nagy

Keyword(s):

Response Rate ◽

Episodic Migraine ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies

Headache The Journal of Head and Face Pain ◽

10.1111/head.13970 ◽

2020 ◽

Vol 60 (10) ◽

pp. 2202-2219

Author(s):

Todd A. Smitherman ◽

Gretchen E. Tietjen ◽

Kory Schuh ◽

Vladimir Skljarevski ◽

Sarah Lipsius ◽

...

Keyword(s):

Medical History ◽

Migraine Prevention ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

History Of ◽

Efficacy of the novel β3 adrenergic receptor agonist vibegron for the treatment of nocturia in patients with overactive bladder: A post hoc analysis of phase 3 study

European Urology Supplements ◽

10.1016/s1569-9056(19)31437-x ◽

2019 ◽

Vol 18 (1) ◽

pp. e1984-e1985

Author(s):

M. Yoshida ◽

M. Takeda ◽

M. Goto ◽

O. Yokoyama ◽

H. Kakizaki ◽

...

Keyword(s):

Overactive Bladder ◽

Adrenergic Receptor ◽

Receptor Agonist ◽

The Novel ◽

Phase 3 ◽

Post Hoc Analysis ◽

Post Hoc ◽

Adrenergic Receptor Agonist

MP33-04 EFFECTS OF THE β3-ADRENOCEPTOR AGONIST, MIRABEGRON, ON QUALITY OF LIFE IN OLDER PATIENTS WITH OVERACTIVE BLADDER: A POST-HOC ANALYSIS OF POOLED DATA FROM 3 RANDOMISED PHASE 3 TRIALS

The Journal of Urology ◽

10.1016/j.juro.2014.02.955 ◽

2014 ◽

Vol 191 (4S) ◽

Cited By ~ 1

Author(s):

Adrian Wagg ◽

Victor Nitti ◽

Con Kelleher ◽

Stephen Auerbach ◽

Mary Beth Blauwet ◽

...

Keyword(s):

Quality Of Life ◽

Overactive Bladder ◽

Older Patients ◽

Phase 3 ◽

Post Hoc Analysis ◽

Pooled Data ◽

Adrenoceptor Agonist ◽

Efficacy of the β3-adrenoceptor Agonist Mirabegron for the Treatment of Overactive Bladder by Severity of Incontinence at Baseline: A Post Hoc Analysis of Pooled Data from Three Randomised Phase 3 Trials

European Urology ◽

10.1016/j.eururo.2014.06.052 ◽

2015 ◽

Vol 67 (1) ◽

pp. 11-14 ◽

Cited By ~ 31

Author(s):

Christopher Chapple ◽

Vik Khullar ◽

Victor W. Nitti ◽

Jeffrey Frankel ◽

Sender Herschorn ◽

...

Keyword(s):

Overactive Bladder ◽

Phase 3 ◽

Post Hoc Analysis ◽

Pooled Data ◽

Adrenoceptor Agonist ◽